DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Maribavir
Maribavir
SAMHD1 . . . and Viral Ways Around It
DMD #9209 1 N-Methylpurine DNA Glycosylase and 8-Oxoguanine
Novel Therapeutics for Epstein–Barr Virus
Clinical Development of Letermovir and Maribavir Overview of Human
Investigating Synergy Between Ribonucleotide Reductase Inhibitors and Cmv Antivirals
The Third International Consensus Guidelinesthe on Management of Cytomegalovirus in Cincinnati, OH
Appendices: V Ervolgonderzoek Medicatieveiligheid
Surveillance of Antimicrobial Consumption in Europe 2013-2014 SURVEILLANCE REPORT
JULY 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
7. Post-Transplant Infection Considerations
13-400 Phrma Stateclinicaltrials MN 120913.Indd
Drug Pipeline Monthly Update June 2021
Human Papillomavirus 16 E7 Inactivator of Retinoblastoma Family Proteins Complements Human Cytomegalovirus Lacking UL97 Protein Kinase
Viropharma Failure Leaves CMV Pipeline Looking Thin
Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients
Real-World Experience with Letermovir in Primary Prophylaxis Of
Stembook 2018.Pdf
Maribavir for Cytomegalovirus Infections After Transplant
Top View
The Effects of Maribavir on the Autophosphorylation of Ganciclovir Resistant Mutants of the Cytomegalovirus UL97 Protein Claire D Shannon-Lowe, Vincent C Emery*
Repurposing of FDA Approved Drugs
Book 2 IJFMT Oct.2020.Indb
Drug Discovery of Nucleos(T)Ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80Th Birthday
Placental Transfer of Letermovir & Maribavir in the Ex
Fast Selection of Maribavir Resistant Cytomegalovirus in a Bone Marrow
Antiviral Drugs for EBV
Orphan Drug Designation List
CMV) Infection
Resistant Cytomegalovirus - Actual Management and Future Directions
(CHMP) Agenda for the Meeting on 21-24 June 2021
The Journal Receives Funding from the Ministry of Science and Higher Education for Promoting Scientific Research
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2019
Australian Statistics on Medicines 2009
Maribavir) Cytomegalovirus (CMV
Drug Repurposing in the Treatment of COVID-19 COVİD-19 Tedavisinde İlaç Yeniden Konumlandırma
Human Cytomegalovirus Infection: a Considerable Issue Following Allogeneic Hematopoietic Stem Cell Transplantation (Review)
Survey of CMV Management in Pediatric Allogeneic HSCT Programs, on Behalf of the Inborn Errors, Infectious Diseases and Pediatric Diseases Working Parties of EBMT
Signature Redacted Signature of Author: Department of Biology January 29, 2020
British Transplant Society Guidelines For
Public Summary of Opinion on Orphan Designation: Maribavir For
Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replicationᰔ† Fu-Zhang Wang, Debasmita Roy, Edward Gershburg,‡ Christopher B
Nhs-England-Drugs-List-V14.1.Pdf
In Silico Repositioning for Dual Inhibitor Discovery of SARS-Cov-2 (COVID- 19) 3C-Like Protease and Papain-Like Peptidase
Study Protocol
Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
The Use of Antimalarial Drugs Against Viral Infection
Infections After Kidney Transplantation: the Bug Bear of Kidney Transplantation in Tropics Gopal Basu*
ARPEC Protocol for Drug Utilization Study
ATC Code Title
Managing CMV in the New Era of Antiviral Therapy Practical Considerations in the HCT Setting Disclosures
Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012